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Amylin is a 37-residue peptide hormone produced by the islet b-cells of pancreas and the formation of
amylin aggregates is strongly associated with b-cell degeneration in type 2 diabetes, as demonstrated by
more than 95% of patients exhibiting amylin amyloid upon autopsy. It is widely recognized that metal ions
such as copper(II) have been implicated in the aggregation process of amyloidogenic peptides such as Ab
and a-synuclein and there is evidence that amylin self-assembly is also largely aﬀected by copper(II). For
this reason, in this work, the role of copper(II) in the aggregation of amylin has been investigated by
several diﬀerent experimental approaches. Mass spectrometric investigations show that copper(II) induces
significant changes in the amylin structure, which decrease the protein fibrillogenesis as observed by ThT
measurements. Accordingly, solid-state NMR experiments together with computational analysis carried out
on a model amylin fragment confirmed the non-fibrillogenic nature of the copper(II) induced aggregated
structure. Finally, the presence of copper(II) is also shown to have a major influence on amylin proneness
to be degraded by proteases and cytotoxicity studies on diﬀerent cell cultures are reported.
Introduction
Conformational disease is a general term often used to identify
a number of disorders that are characterized by aggregation
and deposition of specific proteins. Although the physiological
roles of some of these aggregation-prone proteins have yet to be
fully elucidated,1 it is possible to distinguish several diﬀerent
pathologies depending on the aggregation of a specific protein,
i.e. b-amyloid for Alzheimer’s disease,2 a-synuclein for Parkinson’s
disease, etc. In these diseases, the proteins in question are known
to convert from their native functional state into highly organized
fibrillar aggregates. In the case of amylin,3,4 the observation of
amyloid deposits in islets of Langerhans of individuals with type 2
diabetes was for a long time considered not important, probably
because while researchers studying other pathologies were look-
ing for a protein to blame that could be responsible for the
possible pathogenic mechanism, the research field of type 2
diabetes was already well established andmainly directed towards
the study of insulin resistance.5 Many researchers regarded the
observed failure of beta-cells only as a secondary event due to
some elusive mechanism of ‘‘glucose toxicity’’. In addition, it is
important to note that amylin in mice or rats has a diﬀerent
amino acid sequence, which conforms to the diﬀerent aggrega-
tion properties of amylin molecules.6 Therefore, the use of these
animals as models hindered the recognition of the connection
between amylin aggregation and the pathology.
In recent years, it has been documented that aggregates of
amylin are directly toxic to beta-cells7 and much eﬀort has been
put toward the investigation of the possible factors triggering
such aggregation.8–10 Indeed, a common feature of all amyloid
deposits is the association in situ with a number of cofactors
such as membrane lipids, other proteins, glycosaminoglycans
and metals.11 In the case of amylin, many modulators of its
aggregating properties have been identified.12–21 In this scenario,
the role that somemetal ions play in the aggregation of human22–24
or rat25 amylin and its fragments has also been investigated in
recent years. While zinc(II) ions have been shown to inhibit the
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formation of aggregated and toxic forms of human amylin,22
providing a possible mechanism between the zinc transporter
ZnT8 and type II diabetes,26 the role of copper(II) ions in the
aggregation and dyshomeostasis of amylin has been controver-
sial.27 Indeed, while previous studies correlated the ability of
copper(II) to inhibit amylin fibrillation with toxicity,23,28 others
pointed out that copper(II) may contribute to cytotoxicity by
inducing amylin to form oligomers, which may contribute more
to cell death than fibrils do.24 Mass spectrometry has also been
applied to elucidate the structure of copper(II)–amylin com-
plexes and the putative binding sites.29,30 However, there is a
lack of study regarding the structure of copper(II)-induced
amylin aggregates, which could provide useful information
for developing therapeutic strategies that could inhibit metal-
induced aggregation and maybe even reverse it. Indeed, amylin
homeostasis seems to be regulated also by the action of some
metalloproteases, which have been found to be able to degrade
this hormone.31–33 The further role that copper(II) might play in
modulating the degradation of amylin by these enzymes has
not been studied, even if this metal ion has been proven to be
able to tune the enzymatic activity of some of these metallo-
proteases.34–36 The copper(II)-driven conformational changes in
h-amylin ought to have a large impact on its in vivo homeo-
stasis. Particularly, as the major contribution to amylin catabolism
in vivo seems to be given by its degradation bymetalloproteases,31–33
we have also studied the effect of copper(II) on amylin degradation
by IDE. The latter seems to be involved in the proteolytic processing
of many other different substrates,37,38 which often also function as
modulators of its activity39,40 and degradation of amylin by IDE has
already been reported in the literature.41,42 However, the cleavage
sites of IDE on amylin seem to depend on the particular conditions
used, as different peptide fragments are reported in different
published reports.41,42 In this scenario, considering also the link
that might exist between copper(II) dyshomeostasis and type II
diabetes,43 we have investigated the role of copper(II) ions in the
packing and aggregating processes of human amylin (h-amylin) by
several different experimental approaches. Particularly, information
on the kinetics, the structure and the proneness of amylin aggre-
gates to be degraded by metalloproteases has been obtained and
discussed. Moreover, owing to the observation that amylin recep-
tors, being shared between amylin and beta-amyloid peptides, also
appear to be involved in the pathophysiology of Alzheimer’s dis-
ease44 and thus representing a molecular link between the two
epidemiologically associated conditions, we have also measured the
effect of copper on the toxic activity of h-amylin and its short peptide
17–29 on neuronal and insulinoma cell cultures.
Experimental
Materials and methods
Insulin-degrading enzyme (IDE), His-Tag, rat, recombinant,
Spodoptera frugiperda was purchased from CALBIOCHEM. Sub-
tilysin, Elastase, Chymotrypsin and D2O were purchased from
Sigma, while ZipTipC18 pipette tips were from Millipore (Billerica,
MA, USA). h-Amylin was purchased from BACHEM, while the
17–29 h-amylin fragment was synthesized as reported in ref. 10.
For solid-state NMR measurements labelled 17–29 h-amylin frag-
ments were synthesized: (1) Ser29-labelled with 13C3 and
15N:
[Rt = 20.30 min]. Mass calculated for: 12C56
13C3 H92
14N17
15N O20 =
1376.5; ESI-MS [obsd m/z: (M + H)+ 1377.8]; (2) Val17-labelled with
13C5 and
15N: [Rt = 21.40 min]. Mass calculated for: 12C54
13C5 H92
14N17
15N O20 = 1378.5; ESI-MS [obsd m/z: (M + H)
+ 1379.7]. The
solvent gradients needed for purification of labelled peptides were
the same as that used for the non-labelled 17–29 h-amylin fragment
and are reported in ref. 10.
Simulations
Constant Temperature Molecular Dynamics (CTMD) simula-
tions of the self-assembling of the N-acetylated and C-amydated
17–29 h-amylin fragment were performed by using the software
CHARMM33. The peptide system was modelled by explicitly
considering all heavy atoms and the polar hydrogen atoms
bound to nitrogen and oxygen. The CHARMM 19 potential
function was adopted and default cut-offs for long range
interactions were used, i.e. a shift function of 1 Å was employed
with a cut-off at 7.5 Å for both the electrostatic and van der
Waals terms. Langevin dynamics with a friction value of
0.15 ps1 were used. This friction coefficient is much smaller
than that of water (43 ps1 at 330 K computed as 3pZd/m, where
Z is the viscosity of water at 330 K, and d and m are the effective
diameters, i.e., 2.8 Å, and the mass of a water molecule,
respectively) to allow for sufficient sampling within the time
scale (ns) of the simulations. It has been demonstrated that the
small value of friction coefficient adopted does not influence
the thermodynamic properties of the system, thus ruling out
the possibility of kinetic traps along the aggregation pathway.
The implicit solvent model EEF1 was employed to simulate the
aqueous solvent. The SHAKE algorithm was used to fix the
length of the covalent bonds involving hydrogen atoms; this
option allows reducing the integration time step down to a
value of 2 fs without affecting the reliability of the simulations.
Furthermore, the non-bonded interactions were updated every
ten dynamics steps and the coordinate frames were saved every
20 ps. A 20 ns implicit water MD simulation was performed on
each single peptide at T = 300 K to equilibrate the monomer.
Ten replicas of the equilibrated monomer were then used to
simulate aggregation in water. In the initial positions there
were neither inter- or intra-molecular contacts, i.e. the ten
peptides were completely unfolded and not interacting in
space. All simulations were started from random positions,
orientations and conformation of the peptide copies. The final
assembly was simulated in a cubic box of 600 Å side and
re-equilibrated for 20 ns at 300 K. These conditions correspond
to a final peptide concentration of 10 mM. Additional MD runs
carried out by varying the size of the solvent box (i.e. at different
peptide concentrations) did not modify the outcome of the
simulations. Next, productive MD simulations were carried out
at 300 K for total 1 ms. The polar order parameter was con-
sidered to monitor the aggregation process as described else-
where. The parameter P1, which is widely used to study the
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properties of anisotropic fluids, is defined as:
P1 ¼ 1
N
XN
i¼1
zi
! d!
 
where zi (the director) is a unit vector defining the preferred
direction of alignment, d is the molecular unit vectors linking
the peptide’s N- and C-termini and N is the number of mole-
cules in the simulation box, i.e. ten in the present study.
P1 describes how themolecular vectors point in the same direction,
and discriminates between parallel and antiparallel/mixed ordered
aggregates.
The Root Mean Square Deviation (RMSD) analysis of an
aggregate is usually employed to check the stability of the
simulated system. The RMSD between two structures (corre-
sponding to times ti and ti+1 of the trajectory) is defined as
follows:
RMSD ti þ tiþ1ð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
N
XN
i¼1
r!i tið Þ  r!iþ1 tiþ1ð Þ
 2
vuut
where ri and ri+1 represent the position vectors of the N protein
atoms calculated at time i and i + 1 respectively.
Solid-state NMR
13C CPMAS NMR spectra were recorded at room temperature on
a Varian Infinity plus spectrometer at a Larmor frequency of
75.47 MHz using a 3.2 mm MAS probe spinning at 25 kHz.
TPPM decoupling at a field of 100 kHz was applied during
acquisition of the 13C spectrum. Chemical shifts are quoted relative
to TMS, using adamantane as a secondary external reference.
Mass spectrometry
The peptide fragments generated by the enzymatic digestion of
amylin by IDE were analyzed by using a Finnigan LCQ DECA XP
PLUS ion trap spectrometer operating in positive ion mode and
equipped with an orthogonal ESI source (Thermo Electron
Corporation, USA). Sample solutions were purified using ZIP-
TIPC18 and after dilution with 50 ml of water and 50 ml of
methanol were injected into the ion source at a flow-rate of
5 ml min1, using nitrogen as drying gas. The mass spectro-
meter was operated at a capillary voltage of 46 V and a capillary
temperature of 250 1C, while the spray voltage was 4.3 kV.
Hydrogen/deuterium exchange experiments
The H/D exchange experiments were performed on h-amylin
before and after incubation with copper(II) using a protein :
metal molar ratio of 1 : 10. The latter condition was applied in
order to ensure that the amount of free amylin in solution was
negligible. Indeed, in Fig. S1 of the ESI† the mass spectra and
the peak assignment of three amylin–copper solutions at
various molar ratios are reported. It can be noted that the
1 : 10 molar ratio ensures the maximum amount of amylin–
copper complex (the peak assigned to free amylin is absent in
this case) without the formation of other species other than the
1 : 1 metal–amylin complex. For this reason this molar ratio was
chosen for the H/D exchange and the limited proteolysis
(see below) experiments. The H/D exchange was carried out
as follows: the protein sample (600 pmol ml1) was equilibrated
for 15 min at 25 1C in 10 mM ammonium acetate at pH 7.
Deuterium exchange was initiated by 10-fold diluting the
sample with ammonium acetate 10 mM, previously prepared
using D2O at the appropriate pD. At various exchange times
(from 15 s to 1 h), aliquots of 1.5 nmol of protein were with-
drawn and rapidly analysed by LC/MS by direct injection into a
HPLC coupled to a ZQ single quadrupole instrument (Waters),
using a 30  0.46 mm reverse phase perfusion column (POROS
10 R1, Applied Biosystems). The protein was eluted at a flow
rate of 0.5 ml min1 with a 30–95% CH3CN gradient in 0.1%
TFA in 1 min.
The HPLC analysis was quickly performed with cold solvents
keeping the column in an ice-bath to reduce the H/D back-
exchange kinetics. Under these conditions, deuterium ions
from the amino acid side chains and the peptide C-terminus
are rapidly substituted with hydrogens while exchange from
amide bonds is much slower and can be measured. Duplicate
analyses were performed for each time point.
Limited proteolysis experiments
The limited proteolysis experiments were performed on
h-amylin before and after incubation with copper(II) using a
protein :metal molar ratio of 1 : 10. Protein samples were
individually treated with chymotrypsin, subtilisin and elastase.
Enzymatic digestions were all performed in 50 mM ammonium
hydrogen carbonate pH 7 at 25 1C by using an E : S ratio (w/w) of
1 : 100 in the case of chymotrypsin and 1 : 50 in the case of
subtilisin and elastase. After 2 h incubation, digestion was
stopped by adding trifluoroacetic acid and aliquots of the
peptide mixtures were directly analysed by MALDI-MS.
MALDI-MS analyses were carried out on a Voyager DE-PRO
MALDI TOF (ABI Sciex) mass spectrometer equipped with a
reflectron analyzer and used in delayed extraction mode with
Voyager control software. 1 ml of the peptide mixture was mixed
with an equal volume of a-cyano-4-hydroxycynnamic acid as the
matrix (10 mg ml1 in 0.2% TFA in 70% acetonitrile), loaded
onto the metallic sample plate and air dried. Mass calibration
was performed using the internal standard calibrants added to
the matrix. MALDI-MS data were acquired over a mass range of
250–6000 m/z in positive mode using the software provided by
the manufacturer.
Sample preparation
All peptide samples were subjected to a disaggregating proce-
dure to remove any existing pre-aggregated form before carry-
ing out each experiment. The protocol consists of dissolving
samples in 1,1,1,3,3,3-hexa-fluoro-2-propanol (HFIP) at a
concentration of 1 mg/1 ml and incubating them at 37 1C for
1 h. HFIP is then removed by gentle streaming with argon and
the resulting peptide film is dissolved again in 1 ml of HFIP,
frozen at 30 1C for 4–5 hours and lyophilized overnight. The
lyophilized samples were then solubilized in MilliQ water to a
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concentration of 2  105 M adjusting the pH value just before
the CD or ThT measurements.
Circular dichroism spectroscopy
The circular dichroism (CD) spectra were obtained at 37 1C
under a constant flow of N2 on a Jasco J-810 spectropolarimeter
equipped with a Peltier thermoelectric type temperature control
system. Experimental measurements were conducted at pH 7
using 1 cm or 0.1 cm path length cuvettes. The CD spectra were
recorded in the UV region (190–260 nm) at a peptide concen-
tration of 2  105 M in MilliQ water. The CD spectra were
acquired every 20 min over an experimental time course of
1500 min. CD intensities are expressed as mean residue ellip-
ticity [y](deg cm2 dmol1).
Thioflavin-T assay
Fluorescence emission spectra of Thioflavin-T (ThT) undergo a
red shift upon incorporation into b-sheet amyloid structures.
Fluorescence was monitored as a function of time in a 96-well
plate using a VARIOSKAN plate reader. The measurements were
carried out using, as a control, the time dependence of the
fluorescence of ThT solutions without the peptide. Samples
were monitored over a 1400 min period at an excitation wave-
length of 450 nm and the emission was 480 nm.
Cell cultures and h-amylin cytotoxicity
Human neuroblastoma cell line (SH-SY5Y: ATCCs CRL-2266t)
and insulinoma cell line (RIN-m: ATCCs CRL-2057t) were
cultured in DMEM/F12 medium (1 : 1) and RPMI 1640 respec-
tively, supplemented with 10% (v/v) fetal bovine serum (FBS),
penicillin (50 U ml1) and streptomycin (50 mg ml1). The cells
were maintained in a humidified environment at 37 1C and 5%
CO2 and cultured in 75 cm
2 culture flasks. The medium was
replaced twice a week and cells were splitted upon reaching
about 80% confluence. The day prior to treatment cells were
harvested and seeded in 48-well plates at a density of 25 000
cells per well. The cells were treated as soon as they reached
maximal confluence.
To evaluate the cytotoxicity produced by the h-amylin pep-
tide, insulinoma and neuroblastoma cell cultures were treated
for 48 hours with diﬀerent preparations of 17–29 h-amylin
peptide and full length protein, and viability was then mea-
sured using the classic MTT protocol.
MTT assay
The toxicity of the peptides was measured through the deter-
mination of cell viability of treated cells compared to control
(untreated cells), by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide] assay. The test is based on the ability of the
mitochondrial enzyme, cytochrome c oxidase and succinate dehy-
drogenase to reduce yellow tetrazole into purple formazan that,
being unable to cross the plasma membrane, will accumulate
within the living cells. Solubilization of formazan crystals with an
appropriate detergent will produce a purple solution, and absor-
bance measures will indicate cells viability. After treatment with
the peptide preparations, cell cultures were incubated for 1 hour at
37 1C in the MTT solution (1 mg ml1 in PBS); the formed crystals
were melted with DMSO. After solubilization of the formazan
crystals a microplate reader was used to read the absorbance at
590 nm.
Results and discussion
To study the conformational changes that copper(II) ions could
induce in h-amylin, solutions of the latter (20 mM) were diluted
10-fold by the addition of the appropriate D2O amount and
deuterium incorporation was monitored by sampling the incu-
bation mixture at diﬀerent time intervals followed by cold acid
quenching and fast LC/MS analysis. Since H/D exchange of
amide deuterons occurs very slowly, the increase in the molec-
ular mass of the protein sample constituted a direct measure-
ment of deuterium incorporation at peptide amide linkages.
The number of amide protons exchanged with deuterium in the
native form of h-amylin and the h-amylin–Cu(II) complex as a
function of time is reported in Fig. 1. Native h-amylin showed
two distributions of multiply charged ions in the ES mass
spectra, eventually originating two curves, thus suggesting the
occurrence of two different conformations of the protein hav-
ing a clear difference in the exchange kinetics. Following
60 min of reaction, the two protein conformations exchanged
a total of 25 and 5 hydrogens, respectively, thus indicating the
existence of equilibrium between a higher unstructured con-
formation and a more compact structure. The analysis of the
relative abundances of the two conformers as estimated by
mass peak intensities showed that h-amylin in solution essen-
tially adopts an unstructured conformation with a minor frac-
tion of molecules assuming a more compact structure. Following
Cu-complex formation, we observed the occurrence of a single
compact conformation of h-amylin that exchanged very few
protons. This behaviour almost resembled that of the most
stable conformation observed in the analysis of the isolated
protein. A possible interpretation of the data suggests that in
Fig. 1 Number of amide protons exchanged with deuterium in the native
form of h-amylin and h-amylin–copper(II) complex as a function of time.
h-Amylin showed two distributions of multiply charged ions in the ES mass
spectra, eventually originating two curves indicated 1A and 1B. Discussion
is in the text.
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solution h-amylin gives rise to equilibrium between two con-
formations, with the more unstructured state being the most
populated. The presence of copper(II) greatly shifted the equili-
brium towards the more compact structure that eventually
constitutes the only existing conformer.
A further confirmation of the copper(II)-induced change in
the conformation was obtained by carrying out limited proteo-
lysis experiments using an array of diﬀerent enzymes including
subtilysin, elastase and chymotrypsin in enzyme/substrate
ratios of 1/50 for subtilysin and elastase or 1/100 in the case
of chymotrypsin (see Fig. S2 of the ESI†). Limited proteolysis
was carried out at 37 1C in 50 mM ammonium hydrogen
carbonate hydrolysis buﬀer at pH 7 for 2 h. The MALDI-MS
analyses allowed us to monitor the changes in the cleavage sites
after copper(II) addition (see Fig. 2). It was thus possible to
establish that the copper(II) binding site is located in the region
containing the His18 residue, which is likely the metal binding
site. This result was further confirmed by using IDE as the
amylin proteolytic enzyme (see introduction). Fig. 3 shows that,
in the presence of copper(II), the cleavage sites of IDE on amylin
(determined by the MS detection of the IDE-produced amylin
fragments, data not shown) decreased in number but also,
more importantly, changed drastically. It was particularly inter-
esting that, apart from the expected inhibitory role of copper(II)
in amylin degradation by IDE (data not shown),34,36,45 the
enzyme was no longer able to cut the peptide in the middle
part of its sequence, indicating that conformational changes
driven by copper(II) binding to this segment of peptide chain
render the latter unavailable for enzymatic hydrolysis.
Once it was assessed that copper(II) induces a conforma-
tional change in the h-amylin molecules, we decided to inves-
tigate the aggregation kinetics of h-amylin in the presence and
in the absence of the metal ion. For this purpose, CD as well as
ThT fluorescence measurements were carried out on the var-
ious samples. In Fig. 4 the CD spectra of h-amylin incubated at
37 1C with copper(II) at diﬀerent times are reported together
with the CD profile of the protein alone. In the absence of
copper the polypeptide adopts a random coil conformation,
while in the presence of metal ions h-amylin conformation
shifts toward a mix of random coil and a-helix structures.
Indeed, the minimum near 200 nm undergoes a red shift over
time which indicates a stabilization of an a-helix conformation,
while there is no negative peak at 216 nm over time, confirming
the absence of b-sheet structures.46 Therefore, although copper
induces a conformational change in the h-amylin molecule,
which shifts the equilibrium toward a more structured form
(see MS results), the lack of b-sheet structures as seen by CD
indicates the absence of an induced fibrillar form of the
protein. This result was further confirmed by ThT fluorescence
measurements. Fig. 5 shows the h-amylin ThT kinetics,
recorded at pH 7.0 in the absence and in the presence of
copper(II) (1 : 1 ratio). In the absence of copper(II) a short lag
phase (near 100 min.) followed by a rapid growth of ThT
fluorescence was observed. In contrast, in the presence of
Fig. 2 Main limited proteolytic sites in h-amylin (black blocks) and the copper(II)–h-amylin complex (grey blocks). Chymotrypsin digestion sites: F15, L16,
F23 and L27; elastase digestion sites: A13, S20, L27 and V32; Subtylisin digestion sites: L12, L16, L27, G33 and N35.
Fig. 3 Cleavage sites of IDE on h-amylin as reported in ref. 41 (black solid arrows), as reported in ref. 42 (grey solid arrows), as obtained in this work after
2 h at 37 1C of h-amylin solution (50 mM in PBS), IDE 0.2 mM, without (black dashed arrows) and with (grey dashed arrows) copper(II). Grey amino acidic
residues refer to the amylin portion used as a model for solid-state NMR and computational studies.
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copper the lag phase was almost 3 times longer and the
fluorescence intensity after 600 minutes was more than 2 times
lower, confirming the absence of metal induced fibrillar form
of h-amylin. Indeed, copper(II) induces a conformational
change in the protein that, although is in a more structured
state (H/D exchange MS and CD results), is less prone to
aggregation, in accordance with previous reports.23,46
Finally, in order to get a closer insight into the mechanism
by which copper(II) induces the above reported changes in both
the conformation and aggregation properties of h-amylin, we
have used the 17–29 h-amylin fragment (Fig. 3) in order to carry
out simulations as well as solid-state NMR measurements on
the aggregated state. The reason and the validity of using this
particular peptide portion have already been reported else-
where.10 Fig. 6 shows 13C CPMAS spectra of three 17–29 h-amylin
fragments (A–C). Sample A is the native 17–29 h-amylin fragment,
with U-13C3-15N1-Ser29 isotopic labelling. Sample B is the same
fragment, which has been bound to copper(II) ions in a 1 :1 ratio.
Sample C is the 17–29 h-amylin fragment with U-13C5-15N1 Val17,
which has also been bound to copper(II) ions in a 1 : 1 ratio.
Observed shifts are recorded in ppm (see Table 1), spectra were
recorded at 25 kHz. All spectra displayed a broad peak arising from
natural abundance 13C nuclei, which are present in all residues.
Sample A showed three sharp resonances for the carbonyl, a and b
carbons of the universally labelled Ser29 residue consistent with the
values reported in the literature for full length h-amylin.47 Sample B
clearly displayed shift differences compared to A, consistent with a
hyperfine coupling to the paramagnetic copper(II) ions present.
Only two resonances were observed, which were attributed to the a
and b carbons. This suggests that the carbonyl signal has been
Fig. 4 CD spectra of h-amylin 2  105 M in water recorded at diﬀerent
time intervals with incubation at 37 1C with equimolar copper(II). The
dotted curve refers to the CD profile in the absence of the metal ion
under the same experimental conditions.
Fig. 5 Kinetics of fibril formation monitored by ThT fluorescence of h-
amylin (2  105 M) in water solution at pH = 7 and 37 1C without (solid
line) and with (dotted line) copper(II) (2  105 M).
Fig. 6 13C CPMAS spectra of the 17–29 h-amylin fragments. C: Prepared
using U-13C5-15N1 Val17 and copper(II), B: prepared using U-13C3-15N1
Ser29 and copper(II), A: prepared using U-13C3-15N1 Ser29 only.
Table 1 Chemical shifts observed for 17–29 h-amylin fragments A–C.
Top: reported shifts of Val17 and Ser29 in the full-length h-amylin. Bottom:
observed shifts for 17–29 h-amylin fragments A–C
Literature h-amylin/ppm
Val17 171.7
58.8
34.2
19.6
Ser29 171.9
64.8
54.9
Sample 17–29 h-amylin fragment copper(II)/ppm
C: Val17 125
85
20
B: Ser29 175
85
17–29 h-amylin fragment/ppm
A: Ser29 175
60
50
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broadened due to paramagnetic relaxation effects. Sample C also
displayed large differences in the expected shifts due to paramag-
netic couplings. These data indicate that both Val17 and Ser29
residues at each end of the fragment experience significant para-
magnetic shifts and are therefore both close in space to the
copper(II) ion.
Far-UV CD spectroscopy was also used to monitor the h-
amylin 17–29 peptide conformational changes associated with
fibril formation. Aggregation kinetics monitored by CD spectro-
scopy were measured in the presence of copper(II) at pH 7 in
water as described above, showing that copper(II) modifies the
polypeptide conformation. The CD profile shown in Fig. 7
appears to be a mixture between random coil and folded
structure. The spectra recorded without the metal showed a
typical random coil conformation but after copper(II) addition,
the 222 nm ellipticity increased while the 200 nm ellipticity was
reduced. It is important to note that the CD spectra relevant to
h-amylin 1–37 and the shorter peptide h-amylin 17–29 appear
quite different. The analysis of the CD profiles suggests that
copper(II) coordination brings structuring effects into the poly-
peptide backbone. This should occur particularly in the peptide
region involved in metal ion binding where the coordinated
amino acid residues induce the adoption of a peptide bent
conformation that is mainly driven by the geometrical coordi-
nation preferences of the metal ion and by the stability of the
formed chelate rings. This new locally defined conformation
contributes with distinctive dichroism to the observed spectral
pattern. Such an effect becomes more evident in the CD curves
of the shorter h-amylin 17–29 peptide sequence. The difference
spectra obtained by subtracting the CD traces recorded without
metal from those obtained in the presence of copper(II) should,
in principle, give an indication of the difference in the back-
bone conformation caused by copper(II) complexation. Indeed,
what we observe is that the resultant CD curves give strikingly
similar CD profiles with a positive ellipticity below 200 nm and
a negative signal centred at around 217–220 nm (see Fig. S3 of
the ESI†). This in our opinion strongly suggests, that in both
cases, copper(II) experiences a similar coordination environ-
ment and this can justify the use of the shorter peptide
fragment to study the metal binding site of the full-length
protein.
Finally, CTMD simulations performed at T = 300 K in
implicit water have shown that the ten replicas of the 17–29
h-amylin fragment exhibited low values of both RMSD and its
fluctuations (Fig. 8) thus suggesting that they rapidly collapse
to give a stable, compact structure.
An analysis of the secondary structure percentages averaged
along the entire simulation provided information about the
conformational preferences of the peptide in the condensed
state (Table 2) that was found in agreement with the solid-state
NMR results. Indeed, the purpose of MD simulations is
to support a head-to-tail topological arrangement of 17–29
h-amylin aggregates. This information is important to support
the interpretation of the solid-state NMR experiments. Actually,
Val17 and Ser29 residues at each end of the 17–29 h-amylin
fragment experience significant paramagnetic shifts and are
therefore both close in space to the copper(II) ion. However, the
C-terminus of 17–29 h-amylin is not supposed to bind copper(II)
and, as a consequence, the NMR results may be explained (i)
assuming that copper(II) binds the N-terminus (Val17) of the
peptide and induces the molecule to bend and adopt a
U-shaped structure or (ii) supposing a head-to-tail arrangement
of the peptide aggregates. In general, little is known about the
metal-binding sites in the aggregated state of peptides and it is
difficult to establish by experiments which of these two hypo-
theses holds true when the peptide aggregates. Therefore, we
resorted to CTMD simulations that pointed clearly to a head-to-
tail topological arrangement of the aggregated peptides. All
these simulations were performed in the absence of copper(II)
ions. We are aware that MD simulations performed in the
Fig. 7 CD spectra of the 17–29 h-amylin fragment (2  105 M) recorded
at different time intervals (from 0 to 21 h) at pH 7.0 and at 37 1C in water
solution in the presence of equimolar copper(II).The dotted curve refers to
the CD profile in the absence of the metal ion at the same experimental
conditions.
Fig. 8 RMSD of the ten-meric assembly of the 17–29 h-amylin fragment
in water.
Table 2 Secondary structure averaged along simulation in water (%)
Helix Sheet Coil Turn
0.06 27.72 38.08 34.14
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presence of copper ions would allow a better comparison with
NMR results. However, the presence of a metal ion in the system
would make the use of QM simulations much safer, as they
embody charge polarization and screening, rather than the use
of the purely classical MD adopted in the present work. But an
obvious limitation to the use of QM simulations is the foreseeable
very short length of the computed trajectory (few picoseconds for
systems of the size one is interested in here by using commonly-
available hardware resources), which certainly cannot fully
account for the complicated peptide aggregation dynamics.
The time evolution of the secondary structure for each
replica of the 17–29 h-amylin fragment, reported in Fig. 9,
underlines its high tendency to self-assemble into a beta-sheet
for this system. This observation is consistent with the RMSD
curves of the 17–29 h-amylin fragment in water that are typical
of a structured system with high rigidity and compact packing.
Fig. 10 shows a representative snapshot of the 17–29 h-amylin
fragment aggregated in water. In principle, in the early steps of
aggregation, all amyloidogenic peptides assembled into highly
ordered b-sheet structures. During the assembly, the peptides
tend to align adopting an extended b-strand conformation and
a remarkable change in the local orientational order occurs.
The aggregation of amyloid forming peptides may then be
interpreted as an order transition and orientational order
parameters are suitable to monitor the time evolution of the
process. Fig. 11 reports the projections along the polar order
parameter P1 of the 17–29 h-amylin fragment assemblies cal-
culated as reported in the experimental section. The CTMD
profiles along P1 show that at room temperature T = 300 K
macrostates arranged in an anti-parallel b-sheet configuration
are highly populated (0 o P1 o 0.3). To a lower extent, mixed
parallel/antiparallel arrangements are populated (0.3 o P1 o
0.7). At higher P1 values (P1 4 0.7) where only parallel arrange-
ments are supposed to exist, the CTMD profiles are close to zero
suggesting that parallel arrangements are not likely to be
present during the simulations.
All the observed conformational changes induced by incu-
bation of the peptide alone or in the presence of copper(II)
should aﬀect not only the status of aggregation, but also its
toxic properties. We therefore evaluated the relationship
between aggregating conditions and toxicity in the insulinoma
cell line culture and, in order to provide further proof of the
correlations between diabetes and Alzheimer’s disease, we also
used the neuronal cell line, SH-SY5Y, as the cell culture model.
Cells at full confluence were treated for 48 hours with 17–29
h-amylin preparations (25 mM), which consist of pre-incubation
in vitro alone or in the presence of CuSO4 (in a 1 : 1 molar ratio)
for 48 hours in 0.01 M PBS, pH 7.4. The data obtained showed a
reduced viability (decreased ability to reduce MTT), compared
to control (Fig. 12 and 13), in all the samples treated with 17–29
h-amylin. Any further changes in the status of aggregation
during the 48 h of cell culture treatment cannot be excluded.
This could explain the toxicity exerted by the freshly prepared
(not pre-incubated) peptide (20%). The peptide pre-incubation
Fig. 9 Time evolution of the secondary structure of the 17–29 h-amylin
fragment during the early stages of aggregation (the first 4 ns) in water as
obtained by the analysis of hydrogen bonds in the peptide main chain by
the VMD software. Here, the vertical coordinate represents the residue
number from the first to the 10th replica which is plotted against time. The
secondary structure is color-coded.
Fig. 10 A snapshot of the ten-meric aggregate of the 17–29 h-amylin
fragment in water.
Fig. 11 Percentage of populations of ten-meric 17–29 h-amylin fragment
assemblies plotted along the polar P1, the order parameter. Schematic
representations of the aggregates (black arrows) are depicted to show that
order parameter P1 discriminates between parallel and antiparallel/mixed
ordered aggregates.
Paper Metallomics
Pu
bl
ish
ed
 o
n 
24
 Ju
ly
 2
01
4.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
 D
eg
li 
St
ud
i d
i N
ap
ol
i F
ed
er
ic
o 
II 
on
 2
7/
10
/2
01
5 
07
:4
1:
08
. 
View Article Online
This journal is©The Royal Society of Chemistry 2014 Metallomics, 2014, 6, 1841--1852 | 1849
alone or in the presence of CuSO4 (in a 1 : 1 molar ratio) further
increases its toxicity (40% and 50% of viability respectively).
The stronger decrease in cell viability observed after treatment
with the peptide/copper(II) is in accordance with the ability of
copper to counteract b-sheet conformational changes and
fibrillogenesis, thus prolonging the presence of more toxic
and self-assembling oligomeric species. However it cannot be
excluded that cell viability could also be affected by the for-
mation of toxic free radical species produced in the presence of
copper(II). The treatment of neuroblastoma as well as insuli-
noma cell cultures with h-amylin 1–37 (full protein) prepara-
tions (20 mM) for 48 hours revealed that the amylin toxic effect
was, in this case, not affected by the presence of copper ions
during 48 h of in vitro pre-incubation (Fig. 14 and 15). This
result could be related to and is in agreement with the measured
differences in CD spectra and the absence of metal induced
b-sheet structures (fibrillar form) of h-amylin.
Conclusions
Several diﬀerent experimental techniques as well as CTMD simu-
lations have been applied in order to assess the conformation of
Fig. 12 MTT assay after 48 h of treatment of SHSY5Y cell cultures with
diﬀerent 17–29 h-amylin preparations (25 mM). Data are mean  S.D.
(n = 4) of 3 independent experiments, and expressed as percent vs.
control. Statistical analysis was performed using one way ANOVA, all
Pairwise Multiple Comparison Procedures (Holm–Sidak method): signifi-
cant comparisons are indicated by horizontal curly brackets.
Fig. 13 MTT assay after 48 h of treatment of insulinoma (RIN-m) cell cultures
with diﬀerent h-amylin 17–29 preparations (25 mM). Data are mean  S.D.
(n = 5) of 2 independent experiments, and expressed as percent vs. control.
Statistical analysis was performed using one way ANOVA, all Pairwise Multiple
Comparison Procedures (Holm–Sidak method): significant comparisons are
indicated by horizontal curly brackets.
Fig. 14 MTT assay after 48 h of treatment of neuroblastoma (SHSY5Y) cell
cultures with diﬀerent h-amylin 1–37 preparations (20 mM). Data are
mean  S.D. (n = 5) of 2 independent experiments, and expressed as
percent vs. control. Statistical analysis was performed using one way
ANOVA, all Pairwise Multiple Comparison Procedures (the Holm–Sidak
method): significant comparisons are indicated by horizontal curly brackets.
Fig. 15 MTT assay after 48 h of treatment of insulinoma cell cultures with
diﬀerent h-amylin 1–37 preparations (20 mM). Data are mean  S.D. (n = 4)
of 3 independent experiments, and expressed as percent vs. control.
Statistical analysis was performed using one way ANOVA, all Pairwise
Multiple Comparison Procedures (the Holm–Sidak method): significant
comparisons are indicated by horizontal curly brackets.
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h-amylin in the presence and in the absence of copper(II). The latter
metal ion has been shown to drastically aﬀect both the fiber
structure and aggregation kinetics of h-amylin, as well as its prone-
ness to be degraded by proteases. Particularly, MS data indicate that
h-amylin gives rise to an equilibrium between two conformations,
with the more flexible state being the most populated, while CD
spectra of h-amylin are in accordance with a random coil conforma-
tion and incubation of the peptide alone leads to aggregation. The
presence of copper(II) induces the formation of a more compact
structure that eventually constitutes the only existing conformer.
However, no clear signs of b-sheet conformation could be observed
from the spectroscopic patterns recorded in the presence of
copper(II), thereby suggesting that the metal ion can inhibit
h-amylin fibril formation. The copper(II)-h-amylin species are less
prone to enzyme andmetalloprotease degradation, revealing that the
metal binding has to occur within the 17–29 h-amylin region and the
coordination features of this peptide fragment are in progress. Solid-
state NMR as well as CTMD simulations indicated the presence of
mixed parallel/antiparallel arrangements, confirming the random-
ness of this specific metal ion-induced aggregation process.
These conformational changes can also explain the highest
level of toxicity that we observed after cell culture treatment
with the 17–29 h-amylin fragment preincubated in the presence
of Cu(II) and the absence of effects of copper on h-amylin 1–37
spontaneous evolution towards toxic species.
Finally, we believe that, as copper(II) dyshomeostasis seems
to be involved in the development of type II diabetes, the
reported diﬀerences observed both in the kinetics as well as
in the kind of the aggregates of h-amylin in the presence and in
the absence of copper(II) may have important implications
in vivo which should be further investigated.
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